Sawai not done yet in its pursuit of Kyorin
This article was originally published in Scrip
Executive Summary
In an increasingly dramatic to-and-fro, Sawai Pharmaceutical has yet again refused to give up its pursuit of a merger with Kyorin Holdings, despite a comprehensive rebuff from its larger target earlier this month.